Given the comments during the sharewise webinar regarding multiple NDAs signed, this makes sense and sets the stage.
"cost": CYP shares worth $230,000 to TekCyte. Small dilution for shareholders instead of cutting the cash runway a little shorter. Bargain.
Expect a new licensee.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.010(6.25%) |
Mkt cap ! $33.89M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.0¢ | $56.28K | 372.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 27422 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 94913 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |